🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paul R. Carney

Sunset Laboratory (United States)

ORCID: 0000-0001-6248-1493

Also affiliated with University of Missouri

NeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol”.

Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol

Epilepsy & Behavior(2021)10.1016/j.yebeh.2021.108325

N/A

0.483DataRank · unranked

24 citations

Victoria Evans, Laura M. Gorham, Zhao Liu, Cynthia R. Johnson, Paul R. Carney +1 more

Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy

Journal of Addiction Psychiatry(2024)10.17756/jap.2024-045

N/A

0.208DataRank · unranked

3 citations

Nicole Jafari, David Baron, Abdalla Bowirrat, Albert Pinhasov, Brian Norling +37 more

Psychostimulants for Children: Are We Over or Under Dosing?

Journal of Addiction Psychiatry(2023)10.17756/jap.2023-040

N/A

0.104DataRank · unranked

1 citations

Catherine A. Dennen, Paul R. Carney, Elizabeth Gilley, Panayotis K. Thanos, Eric R. Braverman +7 more

Addiction Risk Polymorphisms Links Autism Spectrum Disorder with Reward Deficiency Syndrome: Insights from GWAS and Pharmacogenomic Meta Analyses

Preprints.org(2025)10.20944/preprints202507.0381.v1

N/A

0DataRank · unranked

0 citations

Kenneth Blum, Kavya Mohankumar, Milan Makale, Abdalla Bowirrat, Albert Pinhasov +23 more

GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents

Preprints.org(2025)10.20944/preprints202510.1849.v1

N/A

0DataRank · unranked

0 citations

Shaurya Mahajan, Alireza Sharafshah, Keerthy Sunder, Kai‐Uwe Lewandrowski, Kavya Mohankumar +22 more

Computational GWAS Meta Meta Analysis Revealing Cross Talk Between Cannabis CNR1 and DRD2 Receptors Optimizing Long-Term Outcomes for Cannabis Use Disorder (CUD) By Enhancing Dopamine Homeostasis Promoting High-Quality Cannabis Medicinals

Research Square(2025)10.21203/rs.3.rs-8140327/v1

N/A

0DataRank · unranked

0 citations

Alireza Sharafshah, Jag Khalsa, Kai-Uwe Lewandrowski, Panayotis K. Thanos, Marco Lindenau +33 more

Cannabidiol – A new fixture in childhood neurology

Current Opinion in Pharmacology(2021)10.1016/j.coph.2021.10.002

N/A

0DataRank · unranked

4 citations

Paul R. Carney, Christopher Anderson

The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies

Open Journal of Immunology(2024)10.4236/oji.2024.143006

N/A

0DataRank · unranked

2 citations

Igor Elman, David Han, Colin Hanna, David Baron, Ashim Gupta +21 more